Poor prognosis indicators of type-2 diabetic COVID-19 patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Medical and Biological Research |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638 |
Resumo: | Diabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis. |
id |
ABDC-1_d4b7ad11ce6add10f20eacb3d26056df |
---|---|
oai_identifier_str |
oai:scielo:S0100-879X2022000100638 |
network_acronym_str |
ABDC-1 |
network_name_str |
Brazilian Journal of Medical and Biological Research |
repository_id_str |
|
spelling |
Poor prognosis indicators of type-2 diabetic COVID-19 patientsSARS-CoV-2C-reactive proteinLactateUreaD-dimerNEWSDiabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis.Associação Brasileira de Divulgação Científica2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638Brazilian Journal of Medical and Biological Research v.55 2022reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x2022e11819info:eu-repo/semantics/openAccessGorjão,R.Hirabara,S.M.Masi,L.N.Serdan,T.D.A.Gritte,R.B.Hatanaka,E.Souza-Siqueira,T.Pithon-Curi,A.C.Lima,T.M. dePithon-Curi,T.C.Marchini,J.F.M.Machado,M.C.C.Souza,H.P.Curi,R.eng2022-06-15T00:00:00Zoai:scielo:S0100-879X2022000100638Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2022-06-15T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false |
dc.title.none.fl_str_mv |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
title |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
spellingShingle |
Poor prognosis indicators of type-2 diabetic COVID-19 patients Gorjão,R. SARS-CoV-2 C-reactive protein Lactate Urea D-dimer NEWS |
title_short |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
title_full |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
title_fullStr |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
title_full_unstemmed |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
title_sort |
Poor prognosis indicators of type-2 diabetic COVID-19 patients |
author |
Gorjão,R. |
author_facet |
Gorjão,R. Hirabara,S.M. Masi,L.N. Serdan,T.D.A. Gritte,R.B. Hatanaka,E. Souza-Siqueira,T. Pithon-Curi,A.C. Lima,T.M. de Pithon-Curi,T.C. Marchini,J.F.M. Machado,M.C.C. Souza,H.P. Curi,R. |
author_role |
author |
author2 |
Hirabara,S.M. Masi,L.N. Serdan,T.D.A. Gritte,R.B. Hatanaka,E. Souza-Siqueira,T. Pithon-Curi,A.C. Lima,T.M. de Pithon-Curi,T.C. Marchini,J.F.M. Machado,M.C.C. Souza,H.P. Curi,R. |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Gorjão,R. Hirabara,S.M. Masi,L.N. Serdan,T.D.A. Gritte,R.B. Hatanaka,E. Souza-Siqueira,T. Pithon-Curi,A.C. Lima,T.M. de Pithon-Curi,T.C. Marchini,J.F.M. Machado,M.C.C. Souza,H.P. Curi,R. |
dc.subject.por.fl_str_mv |
SARS-CoV-2 C-reactive protein Lactate Urea D-dimer NEWS |
topic |
SARS-CoV-2 C-reactive protein Lactate Urea D-dimer NEWS |
description |
Diabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100638 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1414-431x2022e11819 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research v.55 2022 reponame:Brazilian Journal of Medical and Biological Research instname:Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC |
instname_str |
Associação Brasileira de Divulgação Científica (ABDC) |
instacron_str |
ABDC |
institution |
ABDC |
reponame_str |
Brazilian Journal of Medical and Biological Research |
collection |
Brazilian Journal of Medical and Biological Research |
repository.name.fl_str_mv |
Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC) |
repository.mail.fl_str_mv |
bjournal@terra.com.br||bjournal@terra.com.br |
_version_ |
1754302948973740032 |